Probst S, Arber A, Faithfull S. Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs. 2009;13(4):295–8.

Article  PubMed  Google Scholar 

Alexander SJ. An intense and unforgettable experience: the lived experience of malignant wounds from the perspectives of patients, caregivers and nurses. Int Wound J. 2010;7(6):456–65.

Article  PubMed  PubMed Central  Google Scholar 

Grocott P. The palliative management of fungating malignant wounds. J Wound Care. 1995;4(5):240–2.

Article  CAS  PubMed  Google Scholar 

Lund-Nielsen B, Muller K, Adamsen L. Malignant wounds in women with breast cancer: feminine and sexual perspectives. J Clin Nurs. 2005;14(1):56–64.

Article  PubMed  Google Scholar 

Naylor W. Assessment and management of pain in fungating wounds. Br J Nurs. 2001;10(Suppl):S33–56.

Article  CAS  PubMed  Google Scholar 

Knaul FM, Farmer PE, Krakauer EL, et al. Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage. Lancet. 2018;391(10128):1391–454.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

PubMed  Google Scholar 

Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182–6.

Article  CAS  PubMed  Google Scholar 

Seaman S. Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs. 2006;22(3):185–93.

Article  PubMed  Google Scholar 

Browne N, Grocott P, Cowley S, et al. Woundcare Research for Appropriate Products (WRAP): validation of the TELER method involving users of wound care products. Int J Nurs Stud. 2004;41(5):559–71.

Article  PubMed  Google Scholar 

Gethin G, Grocott P, Probst S, Clarke E. Current practice in the management of wound odour: an international survey. Int J Nurs Stud. 2014;51(6):865–74.

Article  PubMed  Google Scholar 

Shirasu M, Touhara K. The scent of disease: volatile organic compounds of the human body related to disease and disorder. J Biochem. 2011;150(3):257–66.

Article  CAS  PubMed  Google Scholar 

Wounds International. Best practice statement: optimising wound care in patients with lower limb lymphoedema and chronic oedema [and related wound odour management principles]. London: Wounds International; 2016.

Google Scholar 

Percival SL, Emanuel C, Cutting KF, Williams DW. Microbiology of the skin and the role of biofilms in infection. Int Wound J. 2012;9(1):14–32.

Article  PubMed  Google Scholar 

Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS Suppl. 2013;136:1–51.

Article  Google Scholar 

Ivory JD, Perrier L, Vellinga A, Sezgin D, Hobbs CM, Ffrench C, et al. A scoping review to identify clinical signs, symptoms and biomarkers reported in the literature to be indicative of biofilm in chronic wounds. Int Wound J. 2025;22(5):e70181. https://doi.org/10.1111/iwj.70181.

Article  PubMed  PubMed Central  Google Scholar 

Malone M, Bjarnsholt T, McBain AJ, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017;26(1):20–5.

Article  CAS  PubMed  Google Scholar 

Drinkwater SL, Smith A, Burnand KG. What can wound fluids tell us about the venous ulcer microenvironment? APMIS. 2002;110(2):127–35.

Google Scholar 

Lo SF, Hayter M, Hu WY, et al. Symptom burden and quality of life in patients with malignant fungating wounds. J Adv Nurs. 2012;68(6):1312–21.

Article  PubMed  Google Scholar 

Chen A, Dusza S, Bromberg J, Goldfarb S, Sanford R, Markova A. Quality of Life in Patients with Malignant Wounds Treated at a Wound Care Clinic. Res Sq [Preprint]. 2024 Sep 2:rs.3.rs-4797536. https://doi.org/10.21203/rs.3.rs-4797536/v1. Update in: Adv Wound Care (New Rochelle). 2025 Nov 10. doi: 10.1177/21621918251393741. PMID: 39281876; PMCID: PMC11398584.

Piggin C, Jones V. Malignant fungating wounds: an analysis of the lived experience. Int J Palliat Nurs. 2007;13(8):384–91.

Article  PubMed  Google Scholar 

Schulz V, Kozell K, Biondo PD, et al. The malignant wound assessment tool: a validation study using a Delphi approach. Palliat Med. 2009;23(3):266–73.

Article  CAS  PubMed  Google Scholar 

Chochinov HM, Hassard T, McClement S, et al. The patient dignity inventory: a novel way of measuring dignity-related distress in palliative care. J Pain Symptom Manage. 2008;36(6):559–71.

Article  PubMed  Google Scholar 

Draper H, Scott C, Ives A. Caring for a caregiver: the experience of family members of patients with malignant wounds. Palliat Med. 2014;28(4):302–10.

Google Scholar 

Probst S, Seppänen S, Gethin G, et al. EWMA Document: home care-wound care: overview, challenges, opportunities and perspectives. J Wound Care. 2014;23(Suppl 5a):S1–44.

PubMed  Google Scholar 

Edwards DI. Nitroimidazole drugs—action and resistance mechanisms. I: mechanisms of action. J Antimicrob Chemother. 1993;31(1):9–20.

Article  CAS  PubMed  Google Scholar 

Gethin G, Vellinga A, McIntosh C, Sezgin D, Probst S, Murphy L, et al. Systematic review of topical interventions for the management of odour in patients with chronic or malignant fungating wounds. J Tissue Viability. 2023;32(1):151–7. https://doi.org/10.1016/j.jtv.2022.10.007.

Article  CAS  PubMed  Google Scholar 

Kalinski C, Schnepf M, Laboy D, et al. Effectiveness of a topical formulation containing metronidazole for wound odor and exudate control. Wounds. 2005;17(4):84–90.

Google Scholar 

Paul JC, Pieper BA. Topical metronidazole for the treatment of wound odor: a review of the literature. Ostomy Wound Manage. 2008;54(3):18–27.

PubMed  Google Scholar 

Trueman P. The use of activated charcoal dressings for malodorous wounds. Prim Intent. 1996;4(1):7–14.

Google Scholar 

Gethin G, Cowman S. Manuka honey vs hydrogel—a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers. J Clin Nurs. 2009;18(3):466–74.

Article  PubMed  Google Scholar 

VowdenK, Cooper RA. An integrated approach to managing wound infection. In: European Wound Management Association (EWMA), position document: identifying criteria for wound infection. London: MEP Ltd; 2005. p. 2–6. https://amca-admin.rachel.puxdesign.cz/CSLR/media/amca/ewma/dokumenty/english_pos_doc_final.pdf

Wolcott RD, Dowd S. The role of biofilms: are we hitting the right target? Plast Reconstr Surg. 2011;127(Suppl 1):S28–35.

Article  Google Scholar 

Bates D, O’Brien C, Kelly L, Keogh S, Price P. The electronic nose: a device for the detection of wound infection in clinical practice. J Wound Care. 2022;31(2):136–46.

Google Scholar 

Hall M, Wall R. Myiasis of humans and domestic animals. Adv Parasitol. 1995;35:257–334.

Article  CAS  PubMed  Google Scholar 

Pinheiro CB, Dorea DP, Neto FL, et al. Wound myiasis caused by Cochliomyia hominivorax in an advanced breast cancer patient: case report and review. Rev Inst Med Trop Sao Paulo. 2019;61:e52.

Google Scholar 

Sherman RA, Hall MJ, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol. 2000;45:55–81.

Article  CAS  PubMed  Google Scholar 

Francesconi F, Lupi O. Myiasis. Clin Microbiol Rev. 2012;25(1):79–105.

Article  PubMed  PubMed Central  Google Scholar 

Gupta AK, Bhattacharya SK. A review of myiasis management: current practice and future perspectives. J Dermatol. 2020;47(2):123–31.

Google Scholar 

Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA. The treatment of scabies with ivermectin. N Engl J Med. 1995;333(1):26–30.

Article  CAS  PubMed